A Randomised, Double-Blind, Dose Ranging Clinical Trial of Intravenous FDY-5301 in Acute STEMI Patients Undergoing Primary PCI: The CAMPFIRE (CArdiac Muscle Preservation Following Ischemia REperfusion) StudyDavid Adlam, CCC-ACS Investigators, Keith G. Oldroyd et al.|Circulation|2019Cited by 1